Search by Drug Name or NDC

    NDC 00006-4094-02 RECOMBIVAX HB 10 ug/mL Details

    RECOMBIVAX HB 10 ug/mL

    RECOMBIVAX HB is a INTRAMUSCULAR; SUBCUTANEOUS INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN.

    Product Information

    NDC 00006-4094
    Product ID 0006-4094_30c061ac-552c-48bc-83fa-95b10e9fc1ee
    Associated GPIs 17100010201820
    GCN Sequence Number 062708
    GCN Sequence Number Description hepatitis B virus vaccine/PF SYRINGE 10 MCG/ML INTRAMUSC
    HIC3 W7B
    HIC3 Description VIRAL/TUMORIGENIC VACCINES
    GCN 98482
    HICL Sequence Number 034649
    HICL Sequence Number Description HEPATITIS B VIRUS VACCINE RECOMBINANT/PF
    Brand/Generic Brand
    Proprietary Name RECOMBIVAX HB
    Proprietary Name Suffix n/a
    Non-Proprietary Name Hepatitis B Vaccine (Recombinant)
    Product Type VACCINE
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR; SUBCUTANEOUS
    Active Ingredient Strength 10
    Active Ingredient Units ug/mL
    Substance Name HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA101066
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-4094-02 (00006409402)

    NDC Package Code 0006-4094-02
    Billing NDC 00006409402
    Package 10 SYRINGE in 1 CARTON (0006-4094-02) / 1 mL in 1 SYRINGE (0006-4094-01)
    Marketing Start Date 1986-07-23
    NDC Exclude Flag N
    Pricing Information N/A